Articles from Valent BioSciences LLC

Valent BioSciences LLC, MGK, and Valent North America LLC announced today they will come together under a new unified organization named Sumitomo Biorational Company LLC (SBC), a subsidiary of Sumitomo Chemical Company Ltd (SCC) in April 2026. Based in Libertyville, Illinois, the integrated organization will serve as SCC’s Global Center of Excellence for Biorational Innovation, designed to accelerate the company’s industry-leading capabilities in providing integrated, sustainable biorational solutions derived from natural sources such as microbials and botanicals to customers around the globe.

The Fertilizer Institute (TFI) has awarded the third certification under its Certified Biostimulant Program to Valent BioSciences for its Transit® 500 biostimulant. The newly launched Certified Biostimulant Program recognizes biostimulant products that have undergone positive reviews of efficacy data, composition, research, safety, and testing methods by TFI and third-party reviewers to confirm adherence to the United States Biostimulant Industry Guidelines.

Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony today. The event included remarks by Valent BioSciences senior leaders, local government and economic development officials, a ribbon cutting, plaque dedication, and refreshments for attendees and company employees.

Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced today that Pace International LLC (Pace) and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space. The decision to divest the Pace International business unit is part of Sumitomo Chemical’s strategic realignment efforts. Sumitomo Chemical and Valent BioSciences also plan to develop a strategic research collaboration with AgroFresh. Under this collaboration, Sumitomo Chemical and Valent BioSciences will continue working together in developing innovative new postharvest solutions and bringing them to the market with AgroFresh’s global market access.

To meet the increasing demands and projected future growth for its industry-leading MycoApply® arbuscular mycorrhizal fungi (AMF) products, Valent BioSciences LLC has announced the construction of a new manufacturing facility in White City, Oregon. This new plant will complement the existing headquarters and manufacturing operations for its subsidiary company, Mycorrhizal Applications LLC, in Grants Pass, Oregon.

Broadening its commitment to sustainability and corporate social value, Valent BioSciences LLC formally dedicated a new prairie park and solar field adjacent to its manufacturing facility in Osage, Iowa, on June 24. The company also opened the doors of its facility to members of the community, enabling them to see firsthand the broad range of sustainable biorational products that are made locally. The open house included remarks from leaders of Valent BioSciences, parent company Sumitomo Chemical Co., Ltd. and community partners, along with tours, informational displays, and a lunch for all attendees.

Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.

Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions. With this acquisition, Valent BioSciences and its parent company, Sumitomo Chemical Co., Ltd., now offer an innovative and proven portfolio of integrated biorational solutions, including biostimulants, biopesticides, and crop nutrition solutions.

The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational. Testing over the past several weeks confirmed that the solar field is functioning as it was intended, which will enable it to produce about 3.4 million kilowatt hours of solar-generated electricity annually. This amount of electricity can power the equivalent of about 425 average-sized homes annually.

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1. The new operating unit was established in February 2022 and it is now fully operational, enabling the organization to serve the entire U.S market. This transition marks a major change in the go-to-market strategy for Valent BioSciences, as the company begins selling biostimulant products directly to U.S. channel partners.

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.

To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities. These enhancements are in addition to the recently announced expansion of the company’s manufacturing facility in Osage, Iowa.

Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity. Construction will begin this summer and will be completed during the second quarter of 2024.

Sumitomo Chemical Company (SCC), parent company of Valent U.S.A. and Valent BioSciences, today announced senior executive appointments, effective April 1.

To further help support the goal of its parent company, Sumitomo Chemical Co., Ltd., to achieve carbon neutral status by 2050, Valent BioSciences LLC announced today that it is establishing a new operating unit designed to expand its biostimulant line with new internally and externally developed products for both the U.S. and global markets in this important and rapidly growing crop production segment.

Valent BioSciences has announced that the U.S. EPA (Environmental Protection Agency) has approved the expanded use of LEAP® ES Bacterial Disease Management Biological Insecticide. As a result of this approval, LEAP ES is now registered for preventative use against cabbage Black Rot and Goss’s Wilt in sweet corn. It was approved previously for use on tomatoes and peppers.

Valent BioSciences LLC announced today that it is undertaking two major environmental initiatives at its biorational manufacturing facility in Osage, Iowa. They include a new prairie restoration project and solar field, both situated on existing Valent BioSciences land, which will provide a variety of benefits to the local community.

Valent BioSciences LLC and Kansas State University, Manhattan, Kansas, announce a formal long-term agreement to advance critical research in the areas of soil health and carbon smart farming. Kansas State University Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice, a world-renowned researcher in carbon cycling and climate change, will oversee this initiative. A portion of the project funding will provide support for a doctoral student and a postdoctoral researcher.

Valent BioSciences LLC announces U.S. EPA (Environmental Protection Agency) registration of a new plant growth regulator (PGR), which will be marketed under the brand name AccedeTM, utilizing the active ingredient 1-aminocyclopropane-1-carboxylic acid (ACC).

Valent BioSciences, the global leader in biorational solutions for Public Health and Integrated Vector Management programs, has introduced MetaLarv® XRP, an innovative new formulation designed specifically for extended residual control of mosquito larvae in catch basins and storm drains.